A A A

Current review panels

Review panels are composed for specific competitions and membership will depend on the expertise needed. Please select the appropriate competition for current information on panel composition.

Note:

For competitions with an LOI stage - panels may be reduced between stages depending on expertise required to review the full application. Panel members participating in the LOI review only will be marked with an *.

For competitions with multiple panels – applicants indicate their panel recommendation, however, final panel selection will be determined by the panel chairs and CCSRI based on the panel with the most appropriate expertise.

Innovation Grant and Innovation to Impact Grant panels

I1a - Biomarkers and Genomics

Including genomics, proteomics, metabolomics (and other ‘omics’), high-throughput sequencing, bioinformatics, diagnostic, prognostic and predictive biomarkers, circulating tumour cells.

Panel meeting: June 10, 2015

Wan Lam, PhD (Chair) BC Cancer Agency
Vancouver, BC
Jim Davie, Phd University of Manitoba
Winnipeg, MB
Robert Day, PhD  University of Sherbrooke
Sherbrooke, QC
Harriet Feilotter, PhD  Queen's University
Kingston, ON
Michael Hendzel, PhD  University of Alberta
Edmonton, AB
Maja Krajinovic, MD/PhD University of Montreal
Montreal, QC
Julian Lum, PhD  BC Cancer Agency
Vancouver, BC
John McPherson, PhD Ontario Institute of Cancer Research
Toronto, ON
Christopher Mueller, PhD Queen’s University
Kingston, ON
Robert Sladek, MD McGill University
Montreal, QC
Anna Goldenberg, PhD (Scientific Officer) The Hospital for Sick Children
Toronto, ON
William Lockwood, PhD (Scientific Officer) BC Cancer Agency
Vancouver, BC
Brian Marshall (Community Representative) Canadian Cancer Society – Ontario Division
Ryan Normore (Community Representative) Canadian Cancer Society – Nova Scotia Division

 

I1b - Gene Regulation & Cell Biology

Including mechanisms of transcriptional control, epigenetics, chromatin structure and function, translational control, RNA biology, post-translational modifications, telomere function, DNA damage and repair, organellar biology, model organisms, angiogenesis, cell migration, cell invasion, tumour environment.

Panel meeting: June 1-2, 2015

John White, PhD (Chair) McGill University
Montreal, QC
David Brindley, PhD University of Alberta
Edmonton, AB
Peter Cheung, PhD York University
Toronto, ON
Frederick Dick, PhD Western University
London, ON
Richard Fahlman, PhD  University of Alberta
Edmonton, AB
Martin Hirst, PhD BC Cancer Agency
Vancouver, BC
Benjamin Kwok, PhD Institute for Research in Immunology and Cancer (IRIC)
Montreal, QC
Shawn Li, PhD Western University
London, ON
C Jane McGlade, PhD The Hospital for Sick Children
Toronto, ON
Nam Sung Moon, PhD McGill University
Montreal, QC
Gil Privé, PhD Princess Margaret Cancer Centre
Toronto, ON
Janusz Rak, MD/PhD McGill University
Montreal, QC
Leonardo Salmena, PhD (Scientific Officer) University of Toronto
Toronto, ON 
Jim Uniacke, PhD (Scientific Officer) University of Guelph
Guelph, ON
Arshia Beigi (Community Representative) Canadian Cancer Society – BC/Yukon Division
Sharon Chandler (Community Representative) Canadian Cancer Society – Ontario Division

 

I2 - Imaging and Technology Development

Including platform and tool development, systems biology, magnetic resonance imaging (MRI), positron emission tomography (PET), ultrasound, computer tomography (CT), radiobiology, radiotherapy, photodynamic therapy (PDT), optical imaging, microfluidics, nanotechnology.

Panel meeting: June 16, 2015

Michael Patterson, PhD (Chair) McMaster University
Hamilton, ON
Wayne Beckham, PhD BC Cancer Agency
Victoria, BC
Guy Cloutier, PhD University of Montreal
Montreal, QC
Daniel Côté, PhD  Laval University
Quebec City, QC 
Masoom Haider, MD Sunnybrook Health Sciences Center
Toronto, ON
Todd Hoare, PhD  McMaster University
Hamilton, ON 
Iwa Kong, MD Juravinski Cancer Centre
Hamilton, ON
Piotr Kozlowski, PhD University of British Columbia
Vancouver, BC
Andrew Minchinton, PhD  BC Cancer Agency
Vancouver, BC 
Mark Niedre, PhD  Northeastern University
Boston, MA
Brian Nieman, PhD  The Hospital for Sick Children
Toronto, ON 
Jacek Tuszynski, PhD  University of Alberta
Edmonton, AB 
Frank Wuest, PhD University of Alberta
Edmonton, AB
Rebecca Thornhill, PhD (Scientific Officer) University of Ottawa
Ottawa, ON
Aaron Ward, PhD (Scientific Officer) London Health Sciences Centre
London, ON
Tanya Gallant (Community Representative)

Canadian Cancer Society – PEI Division

Judy Lund (Community Representative) Canadian Cancer Society – Ontario Division

 

I3 - Immunology, Signalling and Stem Cells

Including metastasis, hormone-sensitive pathways, growth-factor mediated signalling, immunotherapies, viral therapeutics, cancer stem cells, signal transduction, innate immunity and infection, tumour antigens, immune surveillance, hematopoiesis.

Panel meeting: June 10, 2015

Jayne Danska, PhD (Chair) Hospital for Sick Children
Toronto, ON
Ninan Abraham, PhD University of British Columbia
Vancouver, BC
Laurie Ailles, PhD Princess Margaret Cancer Centre
Toronto, ON
Spencer Gibson, PhD  University of Manitoba
Winnipeg, MB 
Stephen Girardin, PhD  University of Toronto
Toronto, ON 
Trang Hoang, PhD Institute for Research in Immunology and Cancer (IRIC)
Montreal, QC
Mark Minden, MD/PhD  Princess Margaret Cancer Centre
Toronto, ON
David Spaner, MD/PhD Sunnybrook Research Institute
Toronto, ON 
David Stojdl, PhD Children's Hospital of Eastern Ontario
Ottawa, ON
Carol Swallow, MD/PhD Mount Sinai Hospital
Toronto, ON
Juan-Carlos Zúñiga-Pflücker, PhD Sunnybrook Research Institute
Toronto, ON
Kevin Kane, PhD (Scientific Officer) University of Alberta
Edmonton, AB
Armand Keating, MD (Scientific Officer) Princess Margaret Cancer Centre
Toronto, ON
Mili Baghela (Community Representative) Canadian Cancer Society – BC/Yukon Division
Angie Woodcock (Community Representative) Canadian Cancer Society – Ontario Division

 

I4 - Novel Therapeutics

Including drug candidates, rational drug design, hit and target validation, compound screening, medicinal chemistry, pharmacology, drug delivery systems, drug transport, drug resistance, combination therapies and pharmacogenomics.

Panel meeting: June 1-2, 2015

Michel Roberge, PhD (Chair) University of British Columbia
Vancouver, BC
David Andrews, PhD Sunnybrook Research Institute
Toronto, ON
Robert Britton, PhD Simon Fraser University
Burnaby, BC
Ann Chambers, PhD  Western University
London, ON 
Elizabeth Gillies, PhD  Western University
London, ON 
Mark Glover, PhD University of Alberta
Edmonton, AB
Sylvain Meloche, PhD Institut de recherches en immunologue/cancer (IRIC)
Montreal, QC
Alain Nepveu, PhD  McGill University
Montreal, QC 
Kevin Petrecca, MD/PhD  McGill University
Montreal, QC 
Lynne-Marie Postovit, PhD  University of Alberta
Edmonton, AB
Christian Steidl, MD BC Cancer Research Centre
Vancouver, BC
Rodger Tiedemann, MD/PhD Princess Margaret Cancer Centre
Toronto, ON
Jeremy Wulff, PhD University of Victoria
Victoria, BC
Anand Swaminath, MD (Scientific Officer) Juravinski Cancer Centre
Hamilton, ON
Geoffrey Tranmer, PhD (Scientific Officer) University of Manitoba
Winnipeg, MB
Dawn Ashforth (Community Representative) Canadian Cancer Society – Ontario Division
Lee Jones (Community Representative) Canadian Cancer Society – Ontario Division

 

I5 - Prevention and Quality of Life 

Including epidemiology, prevention interventions, lifestyle and environmental risk factors, health economics, health services, quality of life, survivorship, palliative care, psychosocial issues, knowledge translation and exchange.

Panel meeting: June 5, 2015

Patricia Parker, PhD (Chair) Memorial Sloan-Kettering Cancer Center
New York, NY
Kristin Campbell, PhD University of British Columbia
Vancouver, BC
Andrea Cherrington, MD  University of Alabama at Birmingham
Birmingham, AL
Hugh Davies, PhD  University of British Columbia, Vancouver, BC 
Mary Jane Esplen, PhD/RN The Toronto Hospital (General Division)
Toronto, ON
Rayjean Hung, PhD Mount Sinai Hospital
Toronto, ON
Karen Kopciuk, PhD  Alberta Health Services
Calgary, AB 
Alice Wei, MD  Princess Margaret Cancer Centre
Toronto, ON
Melanie Keats, PhD (Scientific Officer) Dalhousie University
Halifax, NS
Ryan Kennedy, PhD (Scientific Officer) Propel Centre for Population Health Impact
Waterloo, ON
Carrie Mashinter (Community Representative) Canadian Cancer Society – Ontario Division

 

Impact Grant panel

LOI review teleconference: June 23, 2015
Panel meeting: November 19, 2015

John Bell, PhD (Co-Chair) Ottawa Hospital Research Institute
Ottawa, ON 
Michael Brundage, MD
(Co-Chair)
Kingston General Hospital
Kingston, ON
Samuel Aparicio, PhD BC Cancer Research Centre
Vancouver, BC
Marcel Bally, PhD BC Cancer Agency
Vancouver, BC
Mick Bhatia, PhD McMaster University
Hamilton, ON
Deborah Bowen, PhD University of Washington
Seattle, WA
Shoukat Dedhar, PhD BC Cancer Agency
Vancouver, BC
Steven Gallinger, MD  Toronto General Hospital
Toronto, ON 
Peter Greer, PhD Queen’s University
Kingston, ON
Cynthia Hawkins, MD/PhD  The Hospital for Sick Children
Toronto, ON
Nada Jabado, MD/PhD McGill University
Montreal, QC
Rama Khokha, PhD  Ontario Cancer Institute/PMCC
Toronto, ON 
Nathalie Labrecque, PhD University of Montreal
Montreal, QC
Calum MacAulay, PhD  BC Cancer Agency
Vancouver, BC 
Warren Mason, MD/PhD Princess Margaret Cancer Centre
Toronto, ON
Matthew Parliament, MD  Cross Cancer Institute
Edmonton, AB
Claude Perreault, MD  IRIC
Montreal, QC 
Janet Rossant, PhD The Hospital for Sick Children
Toronto, ON
Gurmit Singh, PhD  McMaster University
Hamilton, ON 
Lillian Siu, MD Princess Margaret Cancer Centre
Toronto, ON
Nahum Sonenberg, PhD McGill University
Montreal, QC
John Spinelli, PhD BC Cancer Agency
Vancouver, BC
Lillian Sung, MD/PhD The Hospital for Sick Children
Toronto, ON
Scott Tyldesley, MD BC Cancer Agency
Vancouver, BC
Jeffrey Wrana, PhD Mount Sinai Hospital
Toronto, ON
Camilla Zimmermann, MD/PhD Princess Margaret Cancer Centre
Toronto, ON

Prevention Research Grant panel

LOI review teleconference: March 31, 2015
Panel meeting: September 30, 2015

Eduardo Franco, MPH/PhD(Chair)  McGill University
Montreal, QC
Irene Andrulis, PhD  Mount Sinai Hospital
Toronto, ON 
Michael Chaiton, PhD University of Toronto
Toronto, ON
Walter Gotlieb, MD/PhD  Jewish General Hospital
Montreal, QC 
Nancy Kreiger, MPH/PhD/FACE Cancer Care Ontario
Toronto, ON
Steve Manske, EdD University of Waterloo
Waterloo, ON
Anthony Miller, MD/FACE University of Toronto
Toronto, ON
Paola Muti, MD McMaster University
Hamilton, ON
Gina Ogilvie, MD/PhD University of British Columbia
Vancouver, BC
Tracy Orleans, PhD Robert Wood Johnson Foundation
Princeton, NJ
Marie-Claude Rousseau, PhD  Institut national de la recherche scientifique
Laval, QC 
Jacques Simard, PhD/FACSS  Centre de recherche du CHU de Québec
Québec, QC 
Ingeborg Zehbe, PhD  Thunder Bay Regional Research Institute
Thunder Bay, ON
Victoria Arrandale, PhD (Scientific Officer) Cancer Care Ontario
Toronto, ON
Rebecca Haines-Saah, PhD (Scientific Officer) University of British Columbia (Okanagan)
Vancouver, BC
Janice Hodgson (Community Representative)  Canadian Cancer Society - Ontario Division 
Nancy Yarmel (Community Representative) Canadian Cancer Society - Ontario Division

CCS-Partner Prevention Research Grant panel

LOI review teleconference: April 29, 2014
Panel meeting: September 30, 2014

Richard (Dick) Clayton, PhD (Chair)  University of Kentucky
Lexington, KY, USA
Tracie Barnett, PhD  University of Montreal
Montreal, QC 
Ulrike (Uli) Boehmer, PhD  Boston University
Boston, MA, USA 
Anne Leis, PhD University of Saskatchewan
Saskatoon, SK
S. Elizabeth McGregor, PhD  Alberta Health Services
Calgary, AB 
Annette Schultz, PhD/RN  University of Manitoba
Winnipeg, MB 
Siobhan Sutcliffe, PhD  Washington University School of Medicine
St. Louis, MO, USA
Shelley Tworoger, PhD  Harvard University
Boston, MA, USA 
Melanie Keats, PhD (Scientific Officer) Dalhousie University
Halifax, NS 
Sylvie Poissant (End User)  Canadian Cancer Society - Quebec Division
Montreal, QC
Anne McTiernan-Gamble (End User)  Canadian Cancer Society - New Brunswick Division
Saint John, NB
Julie Stratton (End User)  Region of Peel, Public Health
Mississauga, ON

Career Development Awards in Prevention panel

Panel meeting: June 18, 2015

Julia Knight, PhD (Chair)  Mount Sinai Hospital
Toronto, ON
Joan L. Bottorff, PhD/RN University of British Columbia Okanagan
Kelowna, BC
Katherine Frohlich, PhD University of Montreal
Montreal, QC
Shelley Harris, PhD CancerCare Ontario
Toronto, ON
Salaheddin Mahmud, PhD University of Manitoba
Winnipeg, MB
Jennifer Yessis, PhD  University of Waterloo
Waterloo, ON

Quality of Life Grant panel

LOI review teleconference: September 18, 2015
Panel meeting: January 14, 2016

Jamie Studts, PhD 
(Chair)
University of Kentucky
Lexington, KY
Natasha Leighl, MD (Chair) Princess Margaret Cancer Centre
Toronto, ON
Cristina Caperchione, PhD University of British Columbia (Okanagan)
Kelowna, BC
Anees Chagpar, MD Yale University
New Haven, CT
S. Robin Cohen, PhD McGill University
Montreal, QC 
Kristine Donovan, PhD/MBA  Moffitt Cancer Center and Research Institute
Tampa, FL
David Eisenstat, MD University of Alberta
Edmonton, AB 
Sophie Lebel, PhD University of Ottawa
Ottawa, ON
Christopher Longo, PhD McMaster University
Hamilton, ON
Donald Mabbott, PhD The Hospital for Sick Children
Toronto, ON
Christine Maheu, PhD McGill University
Montreal, QC 
Suzanne O’Neill, PhD Georgetown University
Washington, DC
Dean Regier, PhD  BC Cancer Agency
Vancouver, BC 
Tara Schapmire, PhD  University of Louisville
Louisville, KY
Allen Sherman, PhD  University of Arkansas
Little Rock, AR 
Marcy Winget, PhD Stanford University
Stanford, CA 
Rebecca Wong, MD  Princess Margaret Cancer Centre
Toronto, ON
James Wright, PhD Juravinski Cancer Centre
Hamilton, ON 
Eitan Amir, PhD (Scientific Officer) Princess Margaret Cancer Centre
Toronto, ON 
LaurenWalker, PhD (Scientific Officer) Tom Baker Cancer Centre
Calgary, AB
Other members to be confirmed.

Knowledge to Action Grant panel

Panel meeting: May 14, 2015

David Chambers, PhD (Chair)  National Cancer Institute
Rockville, MD
Lisa Barbera, PhD  Sunnybrook Research Institute
Toronto, ON 
Jamie Brehaut, PhD  Ottawa Hospital Research Institute
Ottawa, ON 
Nicole Culos-Reed, PhD University of Calgary
Calgary, AB 
Arminee Kazanjian, PhD  University of British Columbia
Vancouver, BC 
Rodger Kessler, PhD University of Vermont
Burlington, VT
Anita Kothari, PhD  Western University
London, ON
Monika Krzyzanowska, MD/MPH  Princess Margaret Cancer Centre
Toronto, ON 
Martine Puts, PhD University of Toronto
Toronto, ON 
Barbara Riley, PhD University of Waterloo
Waterloo, ON
Robert Schwartz, PhD  University of Toronto
Toronto, ON
Marko Simunovic, MD/MPH Juravinski Caner Clinic
Hamilton, ON
Jennifer Brunet, PhD (Scientific Officer)  University of Ottawa
Ottawa, ON 
Shannon Sibbald, PhD (Scientific Officer) Western University
London, ON
Stephen Ng (Community Representative) Canadian Cancer Society - BC/Yukon Division
Sean Nurmsoo (Community Representative) Canadian Cancer Society - Nova Scotia Division

Last modified on: July 31, 2015